GPC2-CAR T cells tuned for low antigen density mediate potent
Por um escritor misterioso
Descrição
Pediatric cancers often mimic fetal tissues and express proteins normally silenced postnatally that could serve as immune targets. We developed T cell…
CAR immune cells: design principles, resistance and the next generation
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity - ScienceDirect
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion - eBioMedicine
Vaccines, Free Full-Text
Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control - Stock - 2023 - International Journal of Cancer - Wiley Online Library
Frontiers Adoptive Cell Therapy in Pediatric and Young Adult Solid Tumors: Current Status and Future Directions
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity - ScienceDirect
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma
CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. - Abstract - Europe PMC
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion - eBioMedicine
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
de
por adulto (o preço varia de acordo com o tamanho do grupo)
